Erez Aminov News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Erez aminov. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Erez Aminov Today - Breaking & Trending Today

Mira Pharmaceuticals Announces DEA Rules MIRA-55, a Novel Oral Pharmaceutical Marijuana Analog, Is Not Classified as a Controlled Substance

Ruling removes potential complications for manufacturing, pre-clinical development, IND submission, clinical development, and ultimately commercialization.
MIAMI, May 29, 2024 /PRNewswire/ MIRA. ....

United States , New York , Erez Aminov , Itzchak Angel , Mira Pharmaceuticals Announces , Securities Exchange , Pharmaceuticals Inc , Us Drug Enforcement Administration , Enforcement Administration , Controlled Substance Act , Not Classified , Controlled Substance , Anti Anxiety Effects , Intoxicating Effects , Chief Scientific Advisor , Controlled Substances Act , Securities Act , Securities Exchange Act , Annual Report ,

MIRA Pharmaceuticals in Discussions with Memorial Sloan Kettering to Collaborate on Preclinical Cancer Pain Model Utilizing The Company's Novel Oral Ketamine Analog

Ketamir-2, the Company s novel oral ketamine analog in development, aims to provide a safe and effective alternative for managing cancer pain and associated depression
MIAMI, May 21, 2024. ....

United States , Erez Aminov , Amitabh Gulati , Itzchak Angel , Sloan Kettering , Pharmaceuticals Inc , Securities Exchange , Board Member Of Cancer Pain Research Consortium , National Cancer Institute , Sloan Kettering Cancer Center , Pharmaceuticals In Discussions , Drug Administration , Pharmaseed Ltd , Sloan Kettering Institute , Memorial Sloan Kettering Cancer Center , Us Drug Enforcement Administration , Memorial Sloan Kettering , Preclinical Cancer Pain , Director Chronic Pain , Board Member , Cancer Pain Research , Investigational New Drug Application , Chief Scientific Advisor , Enforcement Administration , Controlled Substances Act , World Report ,

Mira Pharmaceuticals Advances Preclinical Trials T

MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) ("MIRA" or the "Company"), a pre-clinical-stage pharmaceutical company focused on the treatment of neurologic and ....

United States , Itzchak Angel , Erez Aminov , Scientific Advisor Of Mira Pharmaceuticals , Traumatic Stress Disorder Treatment Market Research , Pharmaseed Ltd , Us Drug Enforcement Administration , National Institutes Of Health , Mira Pharmaceuticals Advances Preclinical Trials , Market Research , Pharmaceuticals Inc , Biotrial Inc , Amira Pharmaceuticals , Drug Administration , Investigational New Drug Application , Preclinical Trials , Head Preclinical Study , Locomotor Activity Evaluation , Day Animal Studies , Good Manufacturing Practices , National Institutes , Cancer Pain , Chief Scientific Advisor , Enforcement Administration , Controlled Substances Act , Clinical Psychiatry ,

Mira Pharma (MIRA) Reports Encouraging Preclinical Results Advancing Ketamir-2 Towards Potential Year-End IND Submission

Mira Pharma (MIRA) Reports Encouraging Preclinical Results Advancing Ketamir-2 Towards Potential Year-End IND Submission
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Erez Aminov , Itzchak Angel , Traumatic Stress Disorder Treatment Market Research , Market Research , Amira Pharmaceuticals , Drug Administration , Amira Pharmaceuticals Inc , Frontage Laboratories , Investigational New Drug Application , Scientific Advisor , Clinical Psychiatry ,

MIRA Pharmaceuticals Releases Breakthrough Data from Artificial Intelligence Simulations

AI Simulation on MIRA1a Showcases Significant Potential Advantages Over Plant-Based Medical Marijuana Related to Anxiety, Appetite and Cognition
BALTIMORE, Dec. 4, 2023 /PRNewswire/ MIRA. ....

Erez Aminov , Adam Kaplin , Drug Administration , Us Drug Enforcement Administration , Pharmaceuticals Inc , Chief Executive Officer , Investigational New Drug , Possible Breakthrough , Anxiety Relief , Appetite Concerns , Chief Scientific Officer , Enforcement Administration , Controlled Substances Act , Registration Statement ,